hnf4α srrna
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2024 (NCT06583993)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatocyte nuclear factor 4-alphaANTISENSE INHIBITOR
HNF4A antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06621173 | Early Phase 1 (Phase 1) | Oct 31, 2024 | Second Military Medical University |
| NCT06583993 | Early Phase 1 (Phase 1) | Sep 30, 2024 | Second Military Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Second Military Medical University | Government | 2 | 2 | 1 | 2024 |
1 organizations
Page 1 / 1